UroSurge Urinary Incontinence Device To Hit U.S. Market In Next 2 Weeks
This article was originally published in The Gray Sheet
Executive Summary
UroSurge says it will launch the Percutaneous Stoller Afferent Nerve Stimulation (SANS) system in the next two weeks for symptomatic treatment of urinary urgency, frequency or urge incontinence. FDA cleared the device Feb. 9 via a de novo 510(k) with clinical trials as a special control.